Navigation Links
Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase
Date:1/13/2014

ROCKVILLE, Md., Jan. 13, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the sixth annual Biotech Showcase (http://www.ebdgroup.com/bts/index.php) in San Francisco on Tuesday, January 14, 3:30 p.m. PT, in Room Powell (Track D). Garr will present a business overview, including updates on ongoing and planned clinical trials. Garr will provide a progress update on NSI-566 cell therapy trials including ALS Phase II, chronic spinal cord injury Phase I, and ischemic stroke Phase I/II in China. Garr will also update the status of its neurogenic NSI-189 small molecule drug which stimulates new neuron growth in the hippocampus, which completed a Phase I safety trial, in major depressive disorder, in the fourth quarter of 2013.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

The audio webcast will be available in real-time at http://www.media-server.com/m/p/p65iz6pt, with replay beginning approximately two hours following the presentation, and archived for one year. The webcast link will also be posted on the Investor Center home page on Neuralstem's website: www.neuralstem.com.

About Neuralstem

Neuralstem's patented technology enables the production of neural stem cells of the brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glial cells. Neuralstem's NSI-566 spinal cord-derived stem cell therapy is in Phase II clinical trials for amyotrophic lateral sclerosis (ALS), often referred to as '/>"/>

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update
2. Neuralstem President And CEO To Present At The 2013 Rodman & Renshaw Annual Healthcare Conference
3. Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
4. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
5. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
6. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
7. Neuralstem Receives Notice Of Issuance For Patent Covering Human Neural Cell Transplantation For Neurodegenerative Conditions
8. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
9. Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
10. Neuralstem Announces Closing of $5.2-Million Registered Direct Offering
11. Neuralstem President and CEO to Present at BIO CEO & Investor Conference 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 06, 2015 Follow us ... of nanomaterial with diameter ranging between 2 to ... global nanophotonics materials market. The unique electroluminescent, photoluminescent, ... to quantum confinement effect render the nanoparticles versatile ... of scientific, technological, and commercial applications. A host ...
(Date:5/6/2015)...   University of Maryland (UM) Ventures and ... of an exclusive option by Biomecite Diagnostics for the ... diagnostics to detect inflammatory bowel diseases (IBD), such as ... Florian Fricke and James White developed ... of Maryland School of Medicine,s Institute for Genome Sciences ...
(Date:5/6/2015)... 2015  Oxis Biotech, Inc. (OXIS), a wholly owned ... today that Cassian Yee , M.D., Professor, Department ... the University of Texas MD Anderson Cancer Center joined ... Department of Immunology, Division of Cancer Medicine, and Director, ... at the University of Texas MD Anderson Cancer Center.  ...
(Date:5/6/2015)... Whitefox ( http://www.whitefox.com ... has signed an agreement with  California ... the delivery of an industrial scale membrane system. The ... water, energy and emissions in the production ... project is fully aligned with ...
Breaking Biology Technology:Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2
... Management Solution innovating the way Misukanis & Odden schedule tasks. ... ... Technologies ( http://info.oneplacehome.com ), creators of the ground breaking ... with their video series "A Day In The Life." The newest ...
... Corporation,(Nasdaq: DRRX ) announced today that ... Alpharma Ireland Limited, an affiliate of,Alpharma Inc. ... the exclusive worldwide,rights to develop and commercialize ... review under the,Hart-Scott-Rodino (HSR) Antitrust Improvements Act ...
... Professors Ichijo and Mano Receive 2008 JCA-Mauvernay ... Debiopharm Group,(Debiopharm), a global biopharmaceutical development specialist ... oncology, presented,Professors Hidenori Ichijo and Hiroyuki Mano ... basic and applied research work in oncology.,The ...
Cached Biology Technology:Riverock Technologies Helps Misukanis & Odden Eliminate Task Management Obstacles 2Riverock Technologies Helps Misukanis & Odden Eliminate Task Management Obstacles 3DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective 2DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective 3DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective 4Japanese Cancer Association and Debiopharm Honour Japanese Research 2Japanese Cancer Association and Debiopharm Honour Japanese Research 3
(Date:4/1/2015)... OXFORD, Conn. , Apr. 1, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... number of Wocket smart wallets is underway to early ... early access group includes usage at retail outlets including ... CVS Pharmacy. Users report Wocket was accepted at all ...
(Date:3/30/2015)... DUBLIN , Mar. 26, 2015 Research and ... addition of the "Global Gesture Recognition Market in ... The analysts forecast the Global Gesture Recognition market ... 12.8% over the period 2013-2018. Gesture recognition ... respond to different gestures of an individual. Gesture recognition ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... - A Purdue University biochemist has demonstrated a process ... their targets, which may help reduce drug side effects. ... analytical chemistry, developed a nanopolymer that can be coated ... which proteins in the cells the drug has entered. ...
... now open! ,You may apply for a Press ... www.eular.org/congress_press_registration.cfm Scientific Programme , The scientific ... The preliminary programme can be accessed online or downloaded ... Abstracts , Abstracts accepted for presentation are made available ...
... Recycling manure is an important practice, especially for large ... in crop production, aiding livestock producers that grow their own ... for crops, it also can contribute to nutrient leaching and ... eutrophication of waterways. The desire for farmers to be able ...
Cached Biology News:Nanopolymer shows promise for helping reduce cancer side effects 2EULAR 2011 media update 2Cost effective manure management 2
... a magnetic bead-based PCR purification ... transfer, centrifugation or filtration steps. ... large PCR extension products in ... AMPure can easily be performed ...
... is a magnetic bead-based PCR ... sample transfer, centrifugation or filtration ... and large PCR extension products ... Agencourt AMPure can easily be ...
... This kit is designed for the fast ... vector plasmids at any position (for the ... loxP-PGK-gb2-neo-loxP cassette is designed to allow neomycin ... cells. It combines a prokaryotic promoter (gb2) ...
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
Biology Products: